<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1885-642X</journal-id>
<journal-title><![CDATA[Pharmacy Practice (Granada)]]></journal-title>
<abbrev-journal-title><![CDATA[Pharmacy Pract (Granada)]]></abbrev-journal-title>
<issn>1885-642X</issn>
<publisher>
<publisher-name><![CDATA[Centro de Investigaciones y Publicaciones Farmacéuticas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1885-642X2021000300005</article-id>
<article-id pub-id-type="doi">10.18549/pharmpract.2021.3.2397</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Evaluation of home medication review for patients with type 2 diabetes mellitus by community pharmacists: a randomised controlled trial]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rosli]]></surname>
<given-names><![CDATA[M Rozaini]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Neoh]]></surname>
<given-names><![CDATA[Chin F]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[David B]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hassan]]></surname>
<given-names><![CDATA[Nazariah W]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mahmud]]></surname>
<given-names><![CDATA[Mahani]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rahimi]]></surname>
<given-names><![CDATA[Afifah]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Karuppannan]]></surname>
<given-names><![CDATA[Mahmathi]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,University of Technology MARA (UiTM) Faculty of Pharmacy ]]></institution>
<addr-line><![CDATA[ Selangor]]></addr-line>
<country>Malaysia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,University of Technology MARA (UiTM) Faculty of Pharmacy ]]></institution>
<addr-line><![CDATA[ Selangor]]></addr-line>
<country>Malaysia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Monash University Malaysia Global Asia in the 21st Century Platform Asian Centre for Evidence Synthesis in Population, Implementation and Clinical Outcomes, Health and Well-Being Cluster]]></institution>
<addr-line><![CDATA[Sunway Town Selangor]]></addr-line>
<country>Malaysia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Pasir Mas City Health Clinic  ]]></institution>
<addr-line><![CDATA[ Kelantan]]></addr-line>
<country>Malaysia</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Hospital Street Pasir Mas City Health Clinic ]]></institution>
<addr-line><![CDATA[Pasir Mas Kelantan]]></addr-line>
<country>Malaysia</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Hospital Street Pasir Mas City Health Clinic ]]></institution>
<addr-line><![CDATA[Pasir Mas Kelantan]]></addr-line>
<country>Malaysia</country>
</aff>
<aff id="Af7">
<institution><![CDATA[,University of Technology MARA (UiTM) Faculty of Pharmacy ]]></institution>
<addr-line><![CDATA[Selangor ]]></addr-line>
<country>Malaysia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2021</year>
</pub-date>
<volume>19</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1885-642X2021000300005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1885-642X2021000300005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1885-642X2021000300005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[ Background: Successful diabetes treatment requires commitment and understanding of disease management by the patients.  Objective: This trial aimed to evaluate the programme effectiveness of home medication review by community pharmacists (HMR-CP) in optimising diabetes care and reducing medication wastage.  Methods: A randomised controlled trial was conducted on 166 patients with Type 2 Diabetes Mellitus (T2DM) who were randomly assigned to the intervention or control groups. The intervention group received HMR-CP at 0-month, 3-month, and 6-month. The primary outcome was haemoglobin A1c (HbA1c) while clinical outcomes, anthropometric data, and humanistic outcomes were the secondary outcomes. For the intervention group, drug-related problems (DRP) were classified according to the Pharmaceutical Care Network Europe Foundation (PCNE). Medication adherence was determined based on the Pill Counting Adherence Ratio (PCAR). The cost of medication wastage was calculated based on the total missed dose by the T2DM patients multiplied by the cost of medication. General linear model and generalised estimating equations were used to compare data across the different time-points within and between the groups, respectively.  Results: No significant difference was observed in the demographic and anthropometric data at baseline between the two groups except for fasting blood glucose (FBG). There was a significant reduction in the HbA1c (-0.91%) and FBG (-1.62mmol/L) over the study period (p&lt;0.05). A similar observation was noted in diastolic blood pressure (DBP) and total cholesterol (TC) but not in high-density lipoprotein (HDL), and anthropometric parameters. Both utility value and Michigan Diabetes Knowledge Test (MDKT) scores increased significantly over time. As for the intervention group, significant changes in PCAR (p&lt;0.001) and the number of DRP (p&lt;0.001) were noted.  Conclusions: HMR-CP significantly improved the glycaemic control, QoL, medication adherence, and knowledge of T2DM patients as well as reduced the number of DRP and cost of medication wastage. However, the impact of HMR-CP on certain clinical and anthropometric parameters remains inconclusive and further investigation is warranted.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Diabetes Mellitus, Type 2]]></kwd>
<kwd lng="en"><![CDATA[Glycemic Control]]></kwd>
<kwd lng="en"><![CDATA[Blood Glucose]]></kwd>
<kwd lng="en"><![CDATA[Glycated Hemoglobin A]]></kwd>
<kwd lng="en"><![CDATA[Pharmaceutical Services]]></kwd>
<kwd lng="en"><![CDATA[Pharmacists]]></kwd>
<kwd lng="en"><![CDATA[Medication Adherence]]></kwd>
<kwd lng="en"><![CDATA[Disease Management]]></kwd>
<kwd lng="en"><![CDATA[Program Evaluation]]></kwd>
<kwd lng="en"><![CDATA[Linear Models]]></kwd>
<kwd lng="en"><![CDATA[Randomized Controlled Trials as Topic]]></kwd>
<kwd lng="en"><![CDATA[Malaysia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tabish]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Is Diabetes Becoming the Biggest Epidemic of the Twenty-first Century?]]></article-title>
<source><![CDATA[Int J Health Sci (Qassim)]]></source>
<year>2007</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>V-VIII</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<source><![CDATA[National Health and Morbility survey Malaysia]]></source>
<year>2019</year>
<publisher-name><![CDATA[Ministry of Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Global Report on Diabetes]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jokanovic]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Sudhakaran]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacist-led medication review in community settings:An overview of systematic reviews]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2017</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>661-85</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Chong]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gillespi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Petrei]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Guidelines For Pharmacists Providing Home Medication Review (HMR) Services]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Klinner]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumer perspectives of the Australian Home Medicines Review Program:benefits and barriers]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2012</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-16</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<source><![CDATA[Home Medication Review Protocol]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Malaysia ]]></publisher-loc>
<publisher-name><![CDATA[Ministry of Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mohamad]]></surname>
<given-names><![CDATA[Rb]]></given-names>
</name>
<name>
<surname><![CDATA[Haron]]></surname>
<given-names><![CDATA[NHb]]></given-names>
</name>
<name>
<surname><![CDATA[Amri]]></surname>
<given-names><![CDATA[Ab]]></given-names>
</name>
</person-group>
<source><![CDATA[Home Care Pharmacy Services Protocol]]></source>
<year>2019</year>
<edition>2</edition>
<publisher-loc><![CDATA[Malaysia ]]></publisher-loc>
<publisher-name><![CDATA[Ministry of Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alias]]></surname>
<given-names><![CDATA[NEB]]></given-names>
</name>
</person-group>
<source><![CDATA[The impact of home medication review in patients with type 2 diabetes mellitus living in rural areas of kuantan]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Malaysia ]]></publisher-loc>
<publisher-name><![CDATA[International Islamic University Malaysia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chow]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Hassali]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Saleem]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Aljadhey]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of pharmacist-led patient education on diabetes-related knowledge and medication adherence:A home-based study]]></article-title>
<source><![CDATA[Health Educ J]]></source>
<year>2015</year>
<volume>75</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>421-33</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Papastergiou]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zervas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Rajan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Home medication reviews by community pharmacists:Reaching out to homebound patients]]></article-title>
<source><![CDATA[Can Pharm J (Ott)]]></source>
<year>2013</year>
<volume>146</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>139-42</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mossialos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Courtin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Naci]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[From &#8220;retailers&#8221; to health care providers:Transforming the role of community pharmacists in chronic disease management]]></article-title>
<source><![CDATA[Health Policy]]></source>
<year>2015</year>
<volume>119</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>628-39</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alotaibi]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[Shivanandappa]]></surname>
<given-names><![CDATA[TB]]></given-names>
</name>
<name>
<surname><![CDATA[Nagarethinam]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contribution of community pharmacists in educating the asthma patients]]></article-title>
<source><![CDATA[Saudi Pharm J]]></source>
<year>2016</year>
<volume>24</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>685-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[CLH]]></given-names>
</name>
<name>
<surname><![CDATA[Gan]]></surname>
<given-names><![CDATA[VBY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacy Value Added Services:Early Begininings, Current Implementation, And Challenges From The Malaysian Experience]]></article-title>
<source><![CDATA[Indian J Pharm Educ Res]]></source>
<year>2016</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>335-43</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bardet]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Vo]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[Bedouch]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Allenet]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physicians and community pharmacists collaboration in primary care:A review of specific models]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2015</year>
<volume>11</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>602-22</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<source><![CDATA[Population Distribution by Local Authority Areas and Mukims]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Malaysia ]]></publisher-loc>
<publisher-name><![CDATA[Department of Statistics]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<source><![CDATA[National Diabetes Registry Report]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Malaysia ]]></publisher-loc>
<publisher-name><![CDATA[Ministry of Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schnedl]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Krause]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Halwachs-Baumann]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Trinker]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lipp]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Krejs]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of HbA1c determination methods in patients with hemoglobinopathies]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2000</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>339-44</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuo]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Niu]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glycated Hemoglobin and Outcomes in Patients with Advanced Diabetic Chronic Kidney Disease]]></article-title>
<source><![CDATA[Sci Rep]]></source>
<year>2016</year>
<volume>6</volume>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stratton]]></surname>
<given-names><![CDATA[IM]]></given-names>
</name>
<name>
<surname><![CDATA[Adler]]></surname>
<given-names><![CDATA[AI]]></given-names>
</name>
<name>
<surname><![CDATA[Neil]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35):prospective observational study]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2000</year>
<volume>321</volume>
<numero>7258</numero>
<issue>7258</issue>
<page-range>405-12</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<source><![CDATA[Diabetes Care]]></source>
<year>2009</year>
<volume>32</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1327-34</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<source><![CDATA[Management of Type 2 Diabetes Mellitus Malaysia]]></source>
<year>2015</year>
<publisher-name><![CDATA[Ministry of Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<source><![CDATA[Classification for Drug related problems]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalogianni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors affect in patient adherence to medication regimen]]></article-title>
<source><![CDATA[Health Sci J]]></source>
<year>2011</year>
<volume>5</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>157-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Nachega]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa]]></article-title>
<source><![CDATA[Curr HIV Res]]></source>
<year>2014</year>
<volume>12</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>366-75</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Butt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mhd Ali]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bakry]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Mustafa]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of a pharmacist led diabetes mellitus intervention on HbA1c, medication adherence and quality of life:A randomised controlled study]]></article-title>
<source><![CDATA[Saudi Pharm J]]></source>
<year>2016</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>40-8</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Group]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
</person-group>
<source><![CDATA[EQ-5D-5L User Guide]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shafie]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Vasan Thakumar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Luo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Rand-Hendriksen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Md Yusof]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EQ-5D-5L Valuation for the Malaysian Population]]></article-title>
<source><![CDATA[Pharmacoeconomics]]></source>
<year>2019</year>
<volume>37</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>715-25</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Qahtani]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Alqarni]]></surname>
<given-names><![CDATA[ASM]]></given-names>
</name>
<name>
<surname><![CDATA[Mohamud]]></surname>
</name>
<name>
<surname><![CDATA[Masuadi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Aldhubayee]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Michigan Diabetes Knowledge Test:translation and validation study of the Arabic version]]></article-title>
<source><![CDATA[Int J Acad Sci Res]]></source>
<year>2016</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>121-5</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al-Qazaz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hassali]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Shafie]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sulaiman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sundram]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The 14-item Michigan Diabetes Knowledge Test:Translation and validation study of the Malaysian version]]></article-title>
<source><![CDATA[Pract Diabetes Int]]></source>
<year>2010</year>
<volume>27</volume>
<page-range>238-41</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karanicolas]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Farrokhyar]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bhandari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Practical tips for surgical research:blinding:who, what, when, why, how?]]></article-title>
<source><![CDATA[Can J Surg]]></source>
<year>2010</year>
<volume>53</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>345-8</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Latif]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Community pharmacy Medicines Use Review:current challenges]]></article-title>
<source><![CDATA[Integr Pharm Res Pract]]></source>
<year>2017</year>
<volume>7</volume>
<page-range>83-92</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Whittlesea]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dhital]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Newbould]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[McCambridge]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Community pharmacist led medication reviews in the UK:A scoping review of the medicines use review and the new medicine service literatures]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2020</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>111-22</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguiar]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Brito Gde]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lima Tde]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Lyra Jr]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Storpirtis]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Investigating Sources of Heterogeneity in Randomized Controlled Trials of the Effects of Pharmacist Interventions on Glycemic Control in Type 2 Diabetic Patients:A Systematic Review and Meta-Analysis]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2016</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e0150999</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ifeanyi Chiazor]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[van Woerden]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Oparah]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Systematic Review of Community Pharmacists' Interventions in Reducing Major Risk Factors for Cardiovascular Disease]]></article-title>
<source><![CDATA[Value Health Reg Issues]]></source>
<year>2015</year>
<volume>7</volume>
<page-range>9-21</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Newman]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[San-Juan-Rodriguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Parekh]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes:An umbrella review]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2020</year>
<volume>16</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1155-65</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fink]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Mooney]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
<name>
<surname><![CDATA[Saseen]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Billups]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center]]></article-title>
<source><![CDATA[Pharm Pract (Granada)]]></source>
<year>2019</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sidek]]></surname>
<given-names><![CDATA[NN]]></given-names>
</name>
<name>
<surname><![CDATA[Xin]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Nurul]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of Pharmacists' Involvement in Home Medication Review (HMR) Among Stroke Patients in Terengganu, Malaysia]]></article-title>
<source><![CDATA[Int J Pharm Pharm Res]]></source>
<year>2017</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>77-86</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mun]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
</person-group>
<source><![CDATA[Evaluation of the impact of Home Medication Review Program on adherence among patients diagnosed with schizophrenia at Kinta district, Malaysia]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Malaysia ]]></publisher-loc>
<publisher-name><![CDATA[USM]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hatah]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Braund]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Tordoff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Duffull]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review and meta-analysis of pharmacist-led fee-for-services medication review]]></article-title>
<source><![CDATA[Br J Clin Pharmacol]]></source>
<year>2014</year>
<volume>77</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>102-15</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="">
<source><![CDATA[MUR premises requirements]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Chater]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Croley]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
</person-group>
<source><![CDATA[Medication therapy management in pharmacy practice:core elements of an MTM service model]]></source>
<year>2008</year>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[American Pharmacist Association]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="">
<collab>Australian Government</collab>
<source><![CDATA[Program Rules Home Medicines Review]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="">
<collab>The Pharmacy Guild of Australia</collab>
<source><![CDATA[Implementing and evaluating a parallel post-discharge Home Medication Review (HMR) model]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andrade]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[CAST]]></given-names>
</name>
<name>
<surname><![CDATA[Neves]]></surname>
<given-names><![CDATA[RCS]]></given-names>
</name>
<name>
<surname><![CDATA[Moreira Jr]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated with high levels of glycated haemoglobin in patients with type 1 diabetes:a multicentre study in Brazil]]></article-title>
<source><![CDATA[BMJ Open]]></source>
<year>2017</year>
<volume>7</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Asif]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern]]></article-title>
<source><![CDATA[J Educ Health Promot]]></source>
<year>2014</year>
<volume>3</volume>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hardavella]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Aamli-Gaagnat]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Frille]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Saad]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Niculescu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Powell]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Top tips to deal with challenging situations:doctor-patient interactions]]></article-title>
<source><![CDATA[Breathe (Sheff)]]></source>
<year>2017</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>129-35</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cai Lian]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bonn]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Si Han]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chin Choo]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Chee Piau]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physical Activity and Its Correlates among Adults in Malaysia:A Cross-Sectional Descriptive Study]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2016</year>
<volume>11</volume>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheah]]></surname>
<given-names><![CDATA[YK]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
<name>
<surname><![CDATA[Kee]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Demographic and lifestyle determinants of time spent in physical activity among Malaysian adolescents [published correction appears in Int J Pediatr Adolesc Med 2020 Dec;7(4):212]]]></article-title>
<source><![CDATA[Int J Pediatr Adolesc Med]]></source>
<year>2018</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>49-54</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hami]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Older people physical activity assessment in Kelantan, Malaysia]]></article-title>
<source><![CDATA[Int J Public Health Clin Sci]]></source>
<year>2017</year>
<volume>4</volume>
<page-range>357</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>51</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khalid]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Raluy-Callado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Curtis]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Boye]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Maguire]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reaney]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rates and risk of hospitalisation among patients with type 2 diabetes:retrospective cohort study using the UK General Practice Research Database linked to English Hospital Episode Statistics]]></article-title>
<source><![CDATA[Int J Clin Pract]]></source>
<year>2014</year>
<volume>68</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>40-8</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>52</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bussell]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Cha]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[YE]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ways Health Care Providers Can Promote Better Medication Adherence]]></article-title>
<source><![CDATA[Clin Diabetes]]></source>
<year>2017</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>171-7</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>53</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheen]]></surname>
<given-names><![CDATA[MHH]]></given-names>
</name>
<name>
<surname><![CDATA[Goon]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Ong]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of a care transition program with pharmacist-provided home-based medication review for elderly Singaporeans at high risk of readmissions]]></article-title>
<source><![CDATA[Int J Qual Health Care]]></source>
<year>2017</year>
<volume>29</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>200-5</page-range></nlm-citation>
</ref>
<ref id="B54">
<label>54</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Onzenoort]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Verberk]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kessels]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension]]></article-title>
<source><![CDATA[Am J Hypertens]]></source>
<year>2010</year>
<volume>23</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>149-54</page-range></nlm-citation>
</ref>
<ref id="B55">
<label>55</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bekker]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Gardarsdottir]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Egberts]]></surname>
<given-names><![CDATA[ACG]]></given-names>
</name>
<name>
<surname><![CDATA[Bouvy]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[van den Bemt]]></surname>
<given-names><![CDATA[BJF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacists'Activities to Reduce Medication Waste:An International Survey]]></article-title>
<source><![CDATA[Pharmacy (Basel)]]></source>
<year>2018</year>
<volume>6</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>94</page-range></nlm-citation>
</ref>
<ref id="B56">
<label>56</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
<name>
<surname><![CDATA[Sun]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Heng]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Chew]]></surname>
<given-names><![CDATA[DEK]]></given-names>
</name>
<name>
<surname><![CDATA[Chong]]></surname>
<given-names><![CDATA[PN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication adherence and glycemic control among newly diagnosed diabetes patients]]></article-title>
<source><![CDATA[BMJ Open Diabetes Res Care]]></source>
<year>2017</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B57">
<label>57</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elliott]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Boyd]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Salema]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supporting adherence for people starting a new medication for a long-term condition through community pharmacies:a pragmatic randomised controlled trial of the New Medicine Service]]></article-title>
<source><![CDATA[BMJ Qual Saf]]></source>
<year>2016</year>
<volume>25</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>747-58</page-range></nlm-citation>
</ref>
<ref id="B58">
<label>58</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marín-Peñalver]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Martín-Timón]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sevillano-Collantes]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Del Cañizo-Gómez]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Update on the treatment of type 2 diabetes mellitus]]></article-title>
<source><![CDATA[World J Diabetes]]></source>
<year>2016</year>
<volume>7</volume>
<numero>17</numero>
<issue>17</issue>
<page-range>354-95</page-range></nlm-citation>
</ref>
<ref id="B59">
<label>59</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nowakowska]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Zghebi]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Ashcroft]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The comorbidity burden of type 2 diabetes mellitus:patterns, clusters and predictions from a large English primary care cohort]]></article-title>
<source><![CDATA[BMC Med]]></source>
<year>2019</year>
<volume>17</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>145</page-range></nlm-citation>
</ref>
<ref id="B60">
<label>60</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[IF]]></given-names>
</name>
<name>
<surname><![CDATA[Garbe]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Economic Costs of Cardiovascular Disease, Diabetes Mellitus, and Associated Complications in South Asia:A Systematic Review]]></article-title>
<source><![CDATA[Value Health Reg Issues]]></source>
<year>2018</year>
<volume>15</volume>
<page-range>12-26</page-range></nlm-citation>
</ref>
<ref id="B61">
<label>61</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abu-Rmeileh]]></surname>
<given-names><![CDATA[NME]]></given-names>
</name>
<name>
<surname><![CDATA[Ghandour]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mataria]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Awawda]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jabr]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[O'Flaherty]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Time to act on diabetes mellitus prevention in the West Bank, oPt:Current and future direct cost of diabetes and its complications]]></article-title>
<source><![CDATA[Obesity Medicine]]></source>
<year>2017</year>
<volume>6</volume>
<page-range>18-22</page-range></nlm-citation>
</ref>
<ref id="B62">
<label>62</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zaman Huri]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Chai Ling]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia]]></article-title>
<source><![CDATA[BMC Public Health]]></source>
<year>2013</year>
<volume>13</volume>
<page-range>1192</page-range></nlm-citation>
</ref>
<ref id="B63">
<label>63</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gangwar]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Monisha]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Nachiya]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Narasingarao]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Parimalakrishnan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of medication and psychological behaviour assessment by community pharmacists in type 2 diabetes mellitus patients after hospital stay]]></article-title>
<source><![CDATA[Afr Health Sci]]></source>
<year>2014</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>539-50</page-range></nlm-citation>
</ref>
<ref id="B64">
<label>64</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Armour]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetes Medication Assistance Service:the pharmacist's role in supporting patient self-management of type 2 diabetes (T2DM) in Australia]]></article-title>
<source><![CDATA[Patient Educ Couns]]></source>
<year>2011</year>
<volume>83</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>288-94</page-range></nlm-citation>
</ref>
<ref id="B65">
<label>65</label><nlm-citation citation-type="book">
<source><![CDATA[National Health and Morbidity Survey]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Malaysia ]]></publisher-loc>
<publisher-name><![CDATA[Ministry of Health]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B66">
<label>66</label><nlm-citation citation-type="book">
<source><![CDATA[Data Asas 2015-2016]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Kelantan ]]></publisher-loc>
<publisher-name><![CDATA[Kelantan State Government]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
